Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boneschi

Showing results (141-150 of 310) with videos related to

Pageof 31
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 30, 2011
CSF metabolites in the differential diagnosis of Alzheimer's disease from frontal variant of frontotemporal dementiaFrancesca de Rino, Filippo Martinelli-Boneschi, Francesca Caso, et al.
Scientific Reports|August 9, 2017
Early involvement of cellular stress and inflammatory signals in the pathogenesis of tubulointerstitial kidney disease due to UMOD mutationsMatteo Trudu, Celine Schaeffer, Michela Riba, et al.
European Journal of Neurology|April 17, 2021
Assessment of the genetic contribution to brain magnetic resonance imaging lesion load and atrophy measures in multiple sclerosis patientsFerdinando Clarelli, Maria Assunta Rocca, Silvia Santoro, et al.
Journal of Neuroimmunology|February 2, 2010
MGAT5 alters the severity of multiple sclerosisB Brynedal, J Wojcik, F Esposito, et al.
Cells|March 23, 2019
Untangling Extracellular Proteasome-Osteopontin Circuit Dynamics in Multiple SclerosisChiara Dianzani, Domizia Vecchio, Nausicaa Clemente, et al.
Open Forum Infectious Diseases|August 13, 2021
Long-Term Coronavirus Disease 2019 Complications in Inpatients and Outpatients: A One-Year Follow-up Cohort StudyMichele Davide Maria Lombardo, Andrea Foppiani, Giuseppe Michele Peretti, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patientsFrancesca Sangalli, Lucia Moiola, Laura Ferrè, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 3, 2010
Comparative study of mitoxantrone efficacy profile in patients with relapsing-remitting and secondary progressive multiple sclerosisFederica Esposito, Marta Radaelli, Vittorio Martinelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2003
Effects of glatiramer acetate on relapse rate and accumulated disability in multiple sclerosis: meta-analysis of three double-blind, randomized, placebo-controlled clinical trialsFilippo Martinelli Boneschi, Marco Rovaris, Kenneth P Johnson, et al.
Brain Pathology (Zurich, Switzerland)|June 29, 2011
Comment on "Cannabinoid receptor and N-acyl phosphatidylethanolamine phospholipase D--evidence for altered expression in multiple sclerosis"Maira Gironi, Nicoletta Pasquariello, Silvia Franchi, et al.
Pageof 31

Showing results (141-150 of 310) with videos related to

Sort By:
Pageof 31
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 30, 2011
CSF metabolites in the differential diagnosis of Alzheimer's disease from frontal variant of frontotemporal dementiaFrancesca de Rino, Filippo Martinelli-Boneschi, Francesca Caso, et al.
Scientific Reports|August 9, 2017
Early involvement of cellular stress and inflammatory signals in the pathogenesis of tubulointerstitial kidney disease due to UMOD mutationsMatteo Trudu, Celine Schaeffer, Michela Riba, et al.
European Journal of Neurology|April 17, 2021
Assessment of the genetic contribution to brain magnetic resonance imaging lesion load and atrophy measures in multiple sclerosis patientsFerdinando Clarelli, Maria Assunta Rocca, Silvia Santoro, et al.
Journal of Neuroimmunology|February 2, 2010
MGAT5 alters the severity of multiple sclerosisB Brynedal, J Wojcik, F Esposito, et al.
Cells|March 23, 2019
Untangling Extracellular Proteasome-Osteopontin Circuit Dynamics in Multiple SclerosisChiara Dianzani, Domizia Vecchio, Nausicaa Clemente, et al.
Open Forum Infectious Diseases|August 13, 2021
Long-Term Coronavirus Disease 2019 Complications in Inpatients and Outpatients: A One-Year Follow-up Cohort StudyMichele Davide Maria Lombardo, Andrea Foppiani, Giuseppe Michele Peretti, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patientsFrancesca Sangalli, Lucia Moiola, Laura Ferrè, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 3, 2010
Comparative study of mitoxantrone efficacy profile in patients with relapsing-remitting and secondary progressive multiple sclerosisFederica Esposito, Marta Radaelli, Vittorio Martinelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2003
Effects of glatiramer acetate on relapse rate and accumulated disability in multiple sclerosis: meta-analysis of three double-blind, randomized, placebo-controlled clinical trialsFilippo Martinelli Boneschi, Marco Rovaris, Kenneth P Johnson, et al.
Brain Pathology (Zurich, Switzerland)|June 29, 2011
Comment on "Cannabinoid receptor and N-acyl phosphatidylethanolamine phospholipase D--evidence for altered expression in multiple sclerosis"Maira Gironi, Nicoletta Pasquariello, Silvia Franchi, et al.
Pageof 31